Log in

ATTBF ABATTIS BIOCEUTICALS CORP OTC · Canada

ABATTIS BIOCEUTICALS CORP (ATTBF) news

ABATTIS BIOCEUTICALS CORP is a public biotech or pharmaceutical company listed on OTC under the ticker ATTBF, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest ABATTIS BIOCEUTICALS CORP news

We have not published a story on ABATTIS BIOCEUTICALS CORP yet. When there is news, it will appear here.

Questions about ABATTIS BIOCEUTICALS CORP

What is the ticker symbol of ABATTIS BIOCEUTICALS CORP?

ABATTIS BIOCEUTICALS CORP trades under the ticker ATTBF on OTC.

Where is ABATTIS BIOCEUTICALS CORP listed?

ABATTIS BIOCEUTICALS CORP is listed on OTC.

Which country or territory is ABATTIS BIOCEUTICALS CORP listed under?

Our directory records ABATTIS BIOCEUTICALS CORP under Canada.

What does ABATTIS BIOCEUTICALS CORP do?

Our directory classifies ABATTIS BIOCEUTICALS CORP as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of ABATTIS BIOCEUTICALS CORP?

The ISIN recorded for ABATTIS BIOCEUTICALS CORP is CA00258G1037.

Does aibio.space cover ABATTIS BIOCEUTICALS CORP?

aibio.space lists ABATTIS BIOCEUTICALS CORP among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to ABATTIS BIOCEUTICALS CORP?

Companies in our directory listed in the same country and business area as ABATTIS BIOCEUTICALS CORP: XORTX Therapeutics, LUCY SCIENTIFIC DISCOVERY INC, Resverlogix, Manzo Pharmaceuticals, Marvel Biosciences, Helix BioPharma.

Investor discussion: ABATTIS BIOCEUTICALS CORP

Members talk about ABATTIS BIOCEUTICALS CORP (ATTBF). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:ATTBF on TradingView.

Listing details

ABATTIS BIOCEUTICALS CORP is a public biotech or pharmaceutical company listed on OTC under the ticker ATTBF, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
ABATTIS BIOCEUTICALS CORP
Ticker
ATTBF
Listing
OTC
Country or territory
Canada
Business scope
Pharmaceuticals: Major
ISIN
CA00258G1037
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.